M2M Pharmaceuticals Ltd., is a contract research organization (CRO) supporting early-stage product development for pharmaceutical, food, biological, and biotechnology companies across the globe as a Fee for Service. As our name suggests, Materials to Medicines, M2M helps in understanding right materials for right product with quality, reproducible and robust data to support inhaled drug delivery. Since inception, our key service has been providing our clients solid-state dossier to understand amorphous materials, and now M2M is helping to develop preclinical inhaled products.